Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 29;5(5):e000266. doi: 10.1099/mgen.0.000266

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1. — Comparing PPS data with phenotypic resistance profiles of the bacterial isolates. (a) Map showing the CMS (white), highlighting the countries contributing data to the PPS (blue), contributing bacterial isolates (red) and contributing to both (magenta). (b) Percentage of the total prescribed antibiotics during the PPS grouped into the main classes. AGly, aminoglycosides; FQ, fluoroquinolones; ML, macrolides; TMT, trimethoprim-sulfobactam; TetCy, tetracyclines. β-Lactams are further split into penicillins, cephalosporins (C1, first generation; C2, second generation; C3, third generation), β-lactam-β-lactamase-inhibitor combinations (BlaInh) and carbapenems (CP). (c) Phenotypic resistance data from the VITEK screening, showing the total number of strains, the main antimicrobial classes are indicated as in (b).